Introduction: A screening process that could provide early and accurate diagnosis or prognosis for Alzheimer’s disease (AD) would enable earlier intervention, and enable current and future treatments to be more effective. Ocular pathology and changes to vision and ocular function are being investigated for early detection and monitoring of AD. Objective: To explore the relationship between pupil flash response (PFR) parameters, AD and brain amyloid plaque burden. Methods: Nineteen AD and seventy healthy control (HC) participants were recruited from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing. Thepotential correlations between PFR parameters and 1) AD and 2) brain amyloid plaque burden in the HC group (as...
Background: Biological information drawn from eye-tracking metrics is providing evidence regarding d...
Alzheimer's disease (AD) is the most common form of dementia affecting the growing aging population ...
The impact of Alzheimer's disease (AD) on the pupillary light response (PLR) is controversial, being...
"Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive deficits and vis...
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive deficits and visu...
Contect: Alzheimer's disease (AD) is usually only diagnosed many years after pathology begins. Earli...
Alzheimer’s disease (AD) is a neurodegenerative disorder and a major public health issue that is ri...
Pathologic changes in cerebral and retinal structures governing the pupillary light reflex occur in ...
The earliest detectable change in Alzheimer’s disease (AD) is the buildup of amyloid plaque in the b...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in dementia and event...
Cortical cholinergic deficiency is prominent in Alzheimer's disease (AD), and published findings of ...
Cortical cholinergic deficiency is prominent in Alzheimer’s disease (AD), and published findings of ...
© 2017 Bentham Science Publishers. Objective: Accumulating evidence suggests that the eye can be use...
The earliest detectable change in Alzheimer\u27s disease (AD) is the buildup of amyloid plaque in th...
Alzheimer’s disease (AD) is the most common form of dementia affecting the growing aging population ...
Background: Biological information drawn from eye-tracking metrics is providing evidence regarding d...
Alzheimer's disease (AD) is the most common form of dementia affecting the growing aging population ...
The impact of Alzheimer's disease (AD) on the pupillary light response (PLR) is controversial, being...
"Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive deficits and vis...
Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive deficits and visu...
Contect: Alzheimer's disease (AD) is usually only diagnosed many years after pathology begins. Earli...
Alzheimer’s disease (AD) is a neurodegenerative disorder and a major public health issue that is ri...
Pathologic changes in cerebral and retinal structures governing the pupillary light reflex occur in ...
The earliest detectable change in Alzheimer’s disease (AD) is the buildup of amyloid plaque in the b...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder resulting in dementia and event...
Cortical cholinergic deficiency is prominent in Alzheimer's disease (AD), and published findings of ...
Cortical cholinergic deficiency is prominent in Alzheimer’s disease (AD), and published findings of ...
© 2017 Bentham Science Publishers. Objective: Accumulating evidence suggests that the eye can be use...
The earliest detectable change in Alzheimer\u27s disease (AD) is the buildup of amyloid plaque in th...
Alzheimer’s disease (AD) is the most common form of dementia affecting the growing aging population ...
Background: Biological information drawn from eye-tracking metrics is providing evidence regarding d...
Alzheimer's disease (AD) is the most common form of dementia affecting the growing aging population ...
The impact of Alzheimer's disease (AD) on the pupillary light response (PLR) is controversial, being...